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In Brief
Sigurdsson et al. report that bile acids unexpectedly function as chemical chaperones that are critically required for alleviating ER stress during expansion of fetal hematopoietic stem cells.
INTRODUCTION
Developmental processes involve interactions of multiple germ layers, tissues, and organs (Arnold and Robertson, 2009; Walck-Shannon and Hardin, 2014) , providing optimal environments in which cells grow and differentiate. During developmental progression, cells often migrate from one niche to another, before they reach their ''home'' tissue (Richardson and Lehmann, 2010) . Discovering what types of factors are implicated in such a complicated mechanism is important for understanding how specific cells are properly regulated.
Hematopoietic stem cells (HSCs) migrate to various sites during development before reaching the bone marrow (BM), where they reside during adulthood (Mikkola and Orkin, 2006) . HSCs resident in the adult BM are predominantly maintained in a dormant state, protecting them from accumulating damages and allowing them to support blood production for an entire lifespan (Morrison and Spradling, 2008) . For this reason, HSCs have the lowest protein synthesis rate within the blood hierarchy of the BM (Signer et al., 2014) . Our previous work demonstrated that HSCs have lower tolerance to stress triggered by un-or mis-folded proteins, so-called endoplasmic reticulum (ER) stress (Walter and Ron, 2011) , upon enhanced growth conditions during ex vivo culture (Miharada et al., 2014) . An increase in abnormal proteins initially activates signals enhancing protein folding and degradation of un-or mis-folded proteins (survival signals), and severe and continuous stress triggers the apoptotic pathway (death signal) (Walter and Ron, 2011) . ER stress was preferentially and rapidly elevated in HSCs, and the addition of tauroursodeoxycholic acid (TUDCA), a specific bile acid (BA) known as a chemical chaperone (Ö zcan et al., 2006) , maintained functional HSCs in vitro by reducing ER stress levels (Miharada et al., 2014) . This higher sensitivity to ER stress may contribute to the integrity of the stem cell pool by selectively removing damaged HSCs (van Galen et al., 2014) .
In sharp contrast to the adult, HSCs actively expand during development in the fetal liver (FL) (Ema and Nakauchi, 2000) , with no apparent triggering of ER-stress related signals. However, the mechanisms enabling HSCs to deal with the higher protein-folding requirement during the expansion phase are altogether unknown.
BAs, the active components of bile, are almost exclusively known for their role in lipid absorption and cholesterol catabolism (Hofmann, 1999) . However, studies have also reported additional roles in metabolism and signal transduction and as chemical chaperones (Watanabe et al., 2006; Nguyen and Bouscarel, 2008; de Aguiar Vallim et al., 2013) . Interestingly, BA is already detected in the FL during HSC expansion (Nakagawa and Setchell, 1990; Itoh and Onishi, 2000) , although its role is unknown. In addition, at this stage, the FL contains no bile duct structures separating blood and bile flow (Strazzabosco and Fabris, 2012) , resulting in an exposure of hematopoietic cells to BAs.
In this work we have discovered a previously unknown role for BAs in developing FL. Our results show that expanding FL-HSCs have an increased level of protein synthesis and that BAs inhibit the elevation of ER stress signals through blocking production of aggregated or un-or mis-folded proteins. The work implies that BAs have a novel role in the FL, enabling higher protein synthesis without stress activation and thus heavily contributing to HSC expansion. they also elevate protein production during this process. We measured the protein synthesis rate in HSCs derived from FL (FL-HSCs) using O-propargyl-puromycin (OP-Puro) (Liu et al., 2012) incorporation in pregnant mice. Previous work reported that the protein synthesis rate in HSCs derived from BM was only half compared with other populations (Signer et al., 2014) . However, FL-HSCs showed comparable or higher intensity of OP-Puro, when compared with total cells in FL ( Figure 1A ). This suggests that protein synthesis in FL-HSCs is comparable with other populations and relatively higher than BM-HSCs. Despite the increased protein production, during the expansion period (E12.5-E15.5), FL-HSCs exhibit a lower expression of ER stress response genes when compared with adult BM-HSCs ( Figures 1B and 1C ; Table S1A ). It has also been reported that ER stress signals and subsequent enhancement of the secretion capacity support growth, differentiation, and maturation of various types of cells (Iwawaki et al., 2009; Saito et al., 2009) . However, this is not the case for HSCs, as both ER stress levels and the secretory pathways are not increased or enhanced in expanding FL-HSCs ( Figure 1D ; Table S1B ). Activated cells that are continuously expanding generally have high expression of ER chaperones (Luo and Lee, 2013) . In turn, ER chaperones provide cells with a larger capacity for protein folding and also reduce the frequency of un-or mis-folded proteins and subsequent triggering of ER stress signals. Seemingly this is not the case in FL-HSCs, as they do not show increased expression of ER chaperones ( Figure 1E ; Table S1C ), suggesting that alternative machineries are implicated in the ER stress regulation of FL-HSCs.
FL-HSC

BM-HSC
Distinct BA Metabolism in FL BAs are synthesized from cholesterol by several key enzymes of the cytochrome P450 superfamily in liver (primary BA) (Lorbek et al., 2012) . One of the key enzymes in primary BA biosynthesis is CYP7A1, catalyzing the first step of the classical pathway. The derivative produced is then either converted to chenodeoxycholic acid (CDCA) or used to produce another major component, cholic acid (CA), through the function of CYP8B1. In addition to being involved in a late step of the classical pathway, CYP27A1 governs the first step of an alternative pathway (the acidic pathway) by initiating a process independent of CYP7A1 that can produce CDCA. Furthermore, mice and rats have a rodent-specific synthetic pathway that produces muricholic acid ( Figure 1F ), and BAs can exist conjugated to either glycine or taurine. Primary BAs are then converted to other BAs by intestinal bacteria (secondary BA) (Hofmann, 1999) , which therefore require implication of adult tissues.
During the HSC expansion period, the FL is largely different from adult liver (AL), as the majority of the cells are hematopoi-etic. In FL, Cyp8b1 and Cyp27a1 are expressed at relatively higher levels than in AL, while Cyp7a1 is lower ( Figure S1A ). To characterize the composition of adult and fetal BAs, we performed mass spectrometry analyses. The results showed that the main proportion of mouse fetal BA was taurocholic acid (TCA), and all BAs in the FL were taurine conjugated, while only 30% was taurine-conjugated form in the AL ( Figures  1G, 1H , S1B, and S1C). Unexpectedly, we also detected secondary BAs (e.g., taurodeoxycholic acid) in the FL samples, suggesting that fetal BA may be mixture of fetal and maternal BAs.
Reduction of BA Levels Leads to Decreased Numbers of FL-HSCs
To address whether the quantity of BA affect HSC expansion in FL, we inhibited the biosynthesis of BA. The expression of Cyp7a1 and Cyp8b1 is tightly regulated by the farnesoid X nuclear receptor (FXR), which has a negative feedback loop when overproduced BAs bind to FXR, resulting in downregulation of these two enzymes ( Figure 1F ) (Lorbek et al., 2012) . The chemical agonist GW4064 also binds to FXR, resulting in decreased BA synthesis through a pseudo feedback signal (Watanabe et al., 2011) . In our study, pregnant mice were intravenously injected with either GW4064 (2.5 mg/kg) or vehicle alone on a daily basis from E10.5-E15.5, and the fetuses were subjected to analyses ( Figure 2A ). Quantitative mass spectrometry demonstrated that GW4064 significantly reduced the quantity of BAs in FL, particularly TCA ( Figures 2B and S2A ). Fetuses derived from GW4064 treated mothers showed slightly smaller size (Figures S2B and S2C) and significantly reduced FL cellularity (Figure S2D) . Flow cytometry analyses revealed that the frequency of Lineage À (LinÀ) cells, representing hematopoietic stem/progenitor cells (HSPCs), were significantly decreased, while Lineage + (Lin+) cells were increased. In contrast, erythroid cells and non-hematopoietic cells remained unchanged (Figures 2C and 2D) . The number of LinÀ cells, c-kit + Sca-I + Lineage À (KSL) cells and CD150 + CD48 À KSL cells (HSCs) in FL were also significantly decreased upon GW4064 treatment ( Figure S2E ), while the numbers of HSCs in BM of the mothers were not affected ( Figure S2F ).
We hypothesized that lowered BA production would induce higher ER stress levels, so intracellular staining of ER stress response genes was performed. Flow cytometry analyses showed elevated GRP78, spliced XBP-1, and CHOP ( Figure 2E ). To further confirm that the ER stress signaling pathway is implicated in the response to decreased BA levels, we utilized CHOP knockout (KO) mice (Zinszner et al., 1998) . CHOP KO cells have an attenuated ER stress response, as treatment with tunicamycin (an ER stress inducer) shows diminished levels of apoptotic (B) Intracellular staining of ER stress-related proteins in FL and BM cells. Relative mean fluorescent intensity (MFI) compared with Lin+ cells is shown (n = 3). (C-E) Gene set enrichment analysis (GSEA) revealed that FL-HSCs showed no enrichment in the expression of ER stress response genes (ER STRESS) (C) and the secretory pathway related genes (SECRETORY PATHWAY) (D). GSEA also revealed that FL-HSCs had rather lower ER chaperone genes (ER CHAPERONES) (E). Genes included in the gene sets are shown in Table S1 . The assay was performed using a published database ; GEO: GSE37000). NES, normalized enrichment score; nominal p, nominal p value; FDR q, false discovery rate q value. (F) Biosynthesis of primary BA and key enzymes involved in the pathways. (G) Composition of BA in FL and AL based on mass spectrometry analyses (n = 3-5) (see also Figures S1B and S1C). cells (Li et al., 2009) . GW4064 was injected into pregnant wildtype (WT) or CHOP KO mice and FL were analyzed. The number of HSCs in the FL of WT mice treated with GW4064 was significantly reduced, while c-kit+ cells were unchanged. In contrast, numbers of FL-HSCs in the CHOP KO fetuses treated with vehicle were slightly lower than WT, but not affected by GW4064 injection ( Figure 2F ). The results clearly showed that the ER stress pathway, in particular the severe signal mediated by CHOP, was involved when the level of BA was reduced. We also confirmed that GW4064 lowering of BA induces apoptosis in FL cells ( Figure S2G ).
To confirm that the effects of GW4064 treatment were due to decreased BA production and subsequent elevation of ER stress levels, two types of rescue experiments were performed:
(1) the effect of reduced BA levels on HSPC number was rescued by supplementation of TCA, and (2) a connection to the ER stress signaling pathway was confirmed using salubrinal, an inhibitor of ER stress-induced apoptosis (Boyce et al., 2005) (Figure 2A ). Mass spectrometry confirmed that intraperitoneal injection of TCA robustly compensated the effect of GW4064 treatment on reduced endogenous BA level ( Figures  2B and S2A ). Unexpectedly, TCA treatment also increased other types of Bas, including secondary BA, possibly because of the enhancement of maternal BA production. Analyses of FL showed that the cellularity was rescued by both TCA and salubrinal, while the decreased body weight was not rescued (Figures 2G and 2H) , suggesting that the decrease in fetal weight was not related to reduced BA levels. Flow cytometry analyses revealed that the decrease in the number of stem/progenitor cells was ameliorated ( Figure 2I ). GW4064 injection resulted in a high ratio of apoptotic cells within the FL-HSPCs (Figure S2G ) that was rescued by co-injection of TCA or salubrinal, resulting in significantly lower levels of apoptotic cells (Figure 2J) . Finally, we evaluated the number of functional HSCs in the FL using in vivo limiting dilution assay. We observed that reduction of BA levels using GW4064 significantly decreased the frequency of HSCs and that both TCA and salubrinal fully rescued the number of functional FL-HSCs (Figure 2K) . These findings strongly suggest that the reduction of HSPCs was caused by ER stress-associated apoptosis, due to reduced BA levels.
Deletion of Cyp27a1 Diminishes Growth of HSPCs in the FL Because GW4064 inhibits the classic pathway through indirectly targeting CYP7A1 and CYP8B1, but not CYP27A1, we analyzed Cyp27a1 KO (Cyp27a1 À/À ) mice (Rosen et al., 1998 ) that lack both classical and acidic pathways, resulting in severe reduction of BA.
Deletion of CYP27A1 in humans is known to be the cause of cerebrotendinous xanthomatosis, caused by the deposition of cholesterol (Cali et al., 1991) . Cyp27a1 À/À mice show reduced BA synthesis in AL, while levels of cholesterol and vitamin D are normal (Rosen et al., 1998) , but no observations have been reported about the hematopoietic system. We have seen that production of BAs in Cyp27a1 À/À adult mice was profoundly impaired, even in pregnant mice ( Figures S3A and S3B ), but profiling of BM cells did not show any major differences ( Figures  S3C-S3E ).
Because previous experiments showed that secondary BAs, derived from the mother, could be detected in FL (Figures 1G, S1B, and S1C), we hypothesized that maternal BAs may also contribute to fetal development. In order to address this, we crossed heterozygous males and heterozygous females but also heterozygous males and homozygous females in order to create a more severe environment in which fetuses develop in low levels of BAs ( Figure 3A) . Mass spectrometry analyses revealed that deletion of Cyp27a1 in fetuses had a very minor effect on BA levels of the fetuses in heterozygous mothers, while fetuses from homozygous mothers showed severely and significantly reduced levels of BA ( Figures 3B and S3F) . Additionally, embryos that developed in homozygous mothers did not have any detectable secondary BA in FL ( Figures 3B and S3F ). This strongly suggests that maternal BAs go to the fetus during development. Fetuses lacking Cyp27a1 derived from heterozygous male and female mice developed normally, and cellularity of FL did not show significant changes ( Figures 3C-3E ). In contrast, Cyp27a1 À/À fetuses developed in homozygous mothers displayed smaller livers, and the cellularity was significantly lower (Figures 3C and 3D ). Of note, body weight of fetuses from heterozygous and homozygous mothers did not show any significant differences, further confirming that reduced body weight seen with GW4064 treatment was not connected to reduced BA levels ( Figure 3E ). In the rescue experiment, either 7.5 mg/kg of TCA or 1.5 mg/kg of salubrinal was intraperitoneally injected in the same time. (B) Mass spectrometry assays for measuring BA levels of GW4064-treated FL with or without TCA. Significance is indicated by either pound signs (for total BA level) or asterisks (for TCA level). Error bars are not shown (see also Figure S2A ). (C and D) Frequency of non-hematopoietic cells (CD45 À Lineage À ), erythrocytes (CD45 À Lineage + ), Lin+ cells (CD45 + Lineage + ), and LinÀ cells (CD45 + Lineage À ) in To further analyze the effect of Cyp27a1 deletion on hematopoietic cell development, FL derived from each genotype were subjected to flow cytometry analyses. Absolute numbers of phenotypic HSPCs were significantly decreased in Cyp27a1 À/À fetuses derived from homozygous mothers, while Cyp27a1 À/À fetuses derived from heterozygous mothers did not show significant changes in any population ( Figure 3F ). Of note, absolute number of phenotypic HSCs in Cyp27a1 +/À fetuses developed in homozygous mothers was also significantly reduced (Figure 3G ). Intracellular staining showed significantly higher levels of CHOP expression in HSCs derived from Cyp27a1 À/À fetuses in homozygous mothers ( Figure 3G ) and annexin-V assay revealed higher proportion of apoptotic cells ( Figure 3H ). These findings suggest that in FL both maternal and fetal BAs contribute to support HSPCs. The number of functional HSCs was determined using in vivo limiting dilution assay, and the results showed that Cyp27a1 À/À FL-HSCs from homozygous mothers contained significantly lower number of HSCs (Figure 3I) . To further confirm the implication of ER stress signals in the reduction of HSC number, salubrinal was injected to pregnant Cyp27a1 À/À female mice. As expected, the defect in cellularity of FL and the number of HSPCs were rescued ( Figures  3C-3I ). Taken together, reduced BA levels in the FL environment induce elevated ER stress that leads to apoptotic cell death, preferentially in HSCs.
BAs Reduce Protein Aggregation and Maintain Functional FL-HSCs
Although the effect of reduced BA levels on the number of HSCs in vivo was clarified, the mechanism of BA function still remained elusive. Because taurine-conjugated BAs are mainly transported into the cytosol via transporters, but not by diffusion (Halilbasic et al., 2013) , we tested whether BAs are taken up by hematopoietic cells. FL-HSPCs were incubated with tritium ( 3 H)-labeled TCA (van der Mark et al., 2014) , and uptake was measured using a scintillation counter. 3 H-TCA was rapidly taken up by both BM (not shown) and FL-HSPCs within 10 min, indicating the existence of active transporters of BA on hematopoietic cells (Figure 4A) . The intracellular level of 3 H-TCA was decreased upon the addition of various non-labeled BAs, suggesting that these BAs were competitively transported to FL-HSPCs without specific affinity for one BA compared with another ( Figure 4B) .
The primary function of BA is to act as a detergent for effective absorption of dietary fats and vitamins. However, our previous work identified TUDCA as a potential factor that maintains functional HSCs in vitro through ER stress reduction (Miharada et al., 2014) , possibly mediated by its chemical chaperone properties (Ö zcan et al., 2006) . We hypothesized that TCA and TUDCA may be working through a similar chaperone mechanism in expanding FL-HSPCs.
Initially, we tested the basic ability of different BAs to prevent protein aggregation in a cell free assay. All BAs we tested, including TCA and TUDCA, showed inhibitory abilities on protein aggregation ( Figure S4A) .
Accumulation of abnormal proteins and protein aggregates is known to occur in many neurodegenerative diseases, including Alzheimer's and Huntington's diseases (Scheper and Hoozemans, 2009 ). There is also a connection between protein aggregates and activation of ER stress-induced apoptosis in these diseases (Scheper and Hoozemans, 2009 ). However, the effect of protein aggregation in HSCs has not been studied. To assess whether BAs can block the formation of protein aggregates upon cell culture, we measured the levels of cytosolic aggregated proteins (aggresomes) in TCA and TUDCA treated FL-HSPCs using ProteoStat staining (Bershtein et al., 2013) . As a positive control, we treated cells with the proteasome inhibitor MG-132, resulting in high levels of aggregated proteins. We defined the clear peak appearing upon MG-132 treatment as the ProteoStathigh population ( Figure 4C ). In vitro cell culture conditions quickly increased the level of aggregated proteins in FL cells, which was most pronounced within the HSC population, although TCA and TUDCA significantly diminished this increase ( Figure 4D ). Consistent with these findings, fresh FL-HSCs from Cyp27a1 À/À fetuses derived from homozygous mothers showed significantly higher levels of protein aggregation, while other genotypes showed a slight increase or no increase at all ( Figure 4E ). Finally, we confirmed whether different BAs can maintain HSC capacity by transplantation of HSCs after in vitro culture (Figure 4F ). Similar to our previous work using BM-HSCs (Miharada et al., 2014) , TUDCA displayed a robust potential to maintain functional FL-HSCs in vitro. In addition, TCA also maintained functional FL-HSC, even after 14 days in culture ( Figure 4G ). The function of TCA in sustaining the stem cell capacity was also confirmed in BM-HSCs (data not shown). In either case, no significant differences were seen in the lineage distribution of engrafted cells upon treatment with TCA or TUDCA ( Figure S4B ).
DISCUSSION
Attempts have been made to understand what are the key positive factors that enable expansion of HSCs in the FL (Zhang and (B) Mass spectrometry assays for measuring BA levels of Cyp27a1 KO FL. Significance is indicated by either pound signs (for total BA level) or asterisks (for TCA level). Error bars are not shown (see also Figure S3F ). (C) Fetuses derived from heterozygous (Cyp27a1 +/À ) mother and homozygous (Cyp27a1 À/À ) mother (E15.5). Yellow arrows indicate FL. (D) Weight of fetuses (5-19 fetuses from 3 mothers). (E) Cellularity of FL. Absolute cell number per weight is shown (5-19 fetuses from 3 mothers). (F) Absolute cell number of LinÀ, KSL, and HSC population in the FL (E15.5) (5-19 fetuses from 3 mothers). (G) MFI of intracellular CHOP staining within LinÀ, KSL, and HSC population in the FL (E15.5) (5-19 fetuses from 3 mothers). (H) Frequency of annexin-V + (apoptotic) cells in LinÀ, KSL, and HSC population (5-19 fetuses from 3 mothers). (I) Limiting dilution competitive transplantation assay of Cyp27a1 À/À FL derived from heterozygous or homozygous mother, with or without salubrinal (Salb) injection (6 or 7 recipient mice per group). *p < 0.05, **p < 0.01, ***p < 0.001. (F) Experimental design of the transplantation assay. One hundred CD150 + CD48 À KSL cells isolated from E15.5 FL derived from Ly-5.1/5.2 fetuses were cultured for 7 or 14 days with or without 100 mM of each BA. Whole culture (donor) was transplanted into lethally irradiated Ly-5.2 mice (recipient) along with 2 3 10 5 total BM cells derived from Ly-5.1 mice (competitor). (G) Transplantation assay of cultured FL-HSCs. Long-term reconstitution of hematopoietic system was monitored by peripheral blood analyses. Data from 16 weeks analysis iare shown (n = 6-8). *p < 0.05, **p < 0.01, ***p < 0.001. Lodish, 2004; Zhang et al., 2006; Chen et al., 2014) , but the mechanism remains a mystery. An integral part of any cellular expansion is proper stress management, which has not been explored in detail in FL-HSC. Our work provides the first evidence that FL-HSCs require suppression of ER stress triggering upon expansion. Interestingly, the ER stress suppression in FL-HSCs is not due to increased expression of ER chaperone genes ( Figure 1D ). In fact, FL-HSCs showed severe impairment in their function upon ex vivo culture that could be rescued by specific BAs, similar to BM-HSCs ( Figure 4G ) (Miharada et al., 2014) , suggesting that ER stress in FL-HSCs is not mitigated by intrinsic regulators.
We show strong evidence that BAs play a key role in suppressing ER stress elevation in expanding FL-HSCs through managing a higher demand of protein synthesis and folding in FL. BAs differ from factors that actively stimulate cell growth, as the numbers of total BM/FL cells and phenotypic HSCs cultured with BA were not changed (data not shown; Miharada et al., 2014) . However reduction of BA levels was critical for HSC frequency (Figures 2K and 3I ). In calculation based on the cellularity and HSC frequency, the number of HSC in the FL was 6.56-fold (GW4064 treatment compared with vehicle treatment) and 6.78-fold (Cyp27a1 À/À fetus in KO mother compared with Cyp27a1 +/À fetus) decrease, respectively ( Figures 2K, 3E , 3I, and S2D). This strongly indicates that BAs are important for supporting HSC growth in the FL.
The implication of the ER stress signaling pathway was clearly demonstrated by the rescue experiments using co-injection of salubrinal ( Figures 2H-2K and 3C-3I) and analyses of CHOP KO mice, in which GW4064 did not show an effect on the reduction of HSCs in the FL derived from CHOP KO fetuses ( Figure 2F ). However, high vulnerability to ER stress in primitive cells is considered a biological strategy to discard defective cells possessing abnormal proteins (van Galen et al., 2014) , so blocking ER stress-induced apoptosis artificially may increase long-lasting risks of malignant hematopoiesis while the number of HSCs is maintained. Therefore, inhibition of protein aggregation by BAs may be important in expansion of FL-HSCs to maintain healthy clones independent of intrinsic modulators, resulting in maximized expansion efficacy.
Our data also revealed that BAs exert their actions through the potential of suppressing an increase in aggregated proteins (Figures 4C-4E ). This unexpected role of BAs seems to be specifically regulated at different levels, for example, importation to the fetus, as FL exclusively contains taurine-conjugated BA that are known to have less toxicity (Hofmann, 2004) . Moreover, we identified one of major BAs, TCA, as the main player in the regulation of FL-HSCs, which is known for its low toxicity. However, it is still unclear what makes up the selectivity in the function of different BAs and their molecular specificity in supporting HSCs ( Figure 4G ). In general, hydrophobic BAs, particularly (T) CDCA, are well known for their toxicity (Hofmann, 1999 (Hofmann, , 2004 Marion et al., 2011) , so the molecular characteristics reflecting the chemical structure might be critical for the function of BAs in FL.
Until now, the composition and role of fetal BA were unknown. This work provides evidence for coordinative regulation of BAs derived from mother and fetus. It is noteworthy that secondary BAs were detected in the FL (Figures 1G, S1B , and S1C). In addition, FL of fetuses grown in Cyp27a1 À/À mothers did not contain secondary BA (Figures 3B and S3F) . These data are clear evidence showing the contribution of maternal BA to the fetal BA pool. Cyp27a1 À/À fetuses from heterozygous mothers did not show a significant difference in FL cellularity. However, Cyp27a1 +/À fetuses from homozygous mothers exhibited a significant decrease in the number of HSCs in comparison with fetuses (including Cyp27a1 À/À ) from heterozygous mothers, indicating a major contribution of maternal BA in FL ( Figure 3F) . The reason for a specific decrease in HSC number within Cyp27a1 +/À fetuses in homozygous mother, but not in LinÀ and KSL cells ( Figure 3F ), could be explained by the high vulnerability of HSCs to ER stress, caused by loss of maternal BA. In contrast, Cyp27a1 À/À fetuses displayed significantly lower HSC numbers compared with Cyp27a1 +/À fetuses from homozygous mothers, indicating a mutual importance of fetal BA ( Figures 3F-3I ). These mouse studies support the concept of ''coordinated contribution'' of maternal and fetal BAs on FL hematopoiesis.
In conclusion, this work has unveiled an unknown and unexpected role of BA in HSC regulation and development. This novel system effectively supports growth of HSCs by preventing the elevation of ER stress levels and protein aggregation. These findings add an important player in the stem cell field that goes a long way toward explaining a missing point within the machineries required for efficient expansion of HSCs in FL.
EXPERIMENTAL PROCEDURES
Mice B6.129-Cyp27a1 tm1Elt /J (Cyp27a1 KO) mice, B6.129S(Cg)-Ddit3 tm2.1Dron /J (CHOP KO) mice, and B6.SJL (Ly-5.1) WT mice were obtained from The Jackson Laboratory. C57BL/6NTac (Ly-5.2) WT mice were obtained from Taconic Biosciences. E15.5 fetuses were collected from timed pregnant mice obtained from either in-house breeding at the animal facility of Lund University or Janvier Labs. All animal experiments were approved by the Lund University Animal Ethical Committee.
Chemical Treatment
A chemical agonist of FXR, GW4064 (Sigma-Aldrich), was dissolved in DMSO with 10 mM of concentration as a stock solution. The stock solution was diluted into PBS, and the diluent was intravenously injected (2.5 mg/kg) into pregnant mice from days 10-15 of the pregnancy. TCA (Sigma-Aldrich) was dissolved in PBS with 5 mg/ml of concentration as a stock solution. The stock solution was diluted to 500 mg/ml, and 300 ml of the diluent was intraperitoneally injected (7.5 mg/kg) into pregnant mice from days 10-15 of pregnancy. Salubrinal (TOCRIS) was dissolved in DMSO with 10 mg/ml of concentration as a stock solution. The stock solution was diluted into PBS with 100 mg/ml, and 300 ml of the diluent was intraperitoneally injected (1.5 mg/kg) into pregnant mice from days 10-15 of pregnancy.
Quantification of Aggregated Proteins (ProteoStat Staining)
FL-HSPCs were cultured for 24 hr or analyzed fresh with ProteoStat staining (Enzo Life Sciences). Cultured cells were treated with the proteasome inhibitor MG-132 (positive control) or 100 mM TCA and TUDCA. Cultured and fresh HSPCs were collected and stained with anti-CD48, -c-kit, -Sca-I, -Lineage antibody mix and Zombie Aqua fixable viability dye (BioLegend) for 30 min. Cells were fixed in Cytofix/Cytoperm Fixation and Permeabilization Solution (BD) for 30 min. Fixed cells were stained with the ProteoStat dye (1:10,000) dilution in permeabilization solution for 30 min. Cells were washed and analyzed on FACS LSRII or FACS AriaIII (BD).
In vitro culture of purified HSCs and c-kit + cells
Sorted HSCs or c-kit + cells were cultured in the serum-free medium (StemSpan®SFEM, StemCell Technologies) supplemented with 100 ng/ml of SCF, 100 ng/ml of TPO (Peprotech), and with/without following BA: TUDCA, TCA, TCDCA (Sigma), T-α-MCA (Toronto Research Chemicals) and T-β-MCA (Santa Cruz). All BA were dissolved in ethanol and same concentration of ethanol was used as control.
Long-term competitive repopulation assay
Competitive repopulation assay was performed by using the Ly-5 congenic mouse system. One hundred freshly isolated cells or all the cultured cells (donor) were mixed with 2 x10 5 total bone marrow (competitor) cells, and then transplanted into mice irradiated with 900 cGy (recipient). Every 4 weeks after transplantation, peripheral blood from tail vein of recipient mice was collected and stained with anti-CD45.1 (Ly-5.1), -CD45.2 (Ly-5.2), -CD3, -Gr-1, -CD11b, and -B220 antibodies after red blood cell lysis using NH 4 Cl.
Limiting dilution assay (competitive repopulation unit assay) was performed to calculate the frequency of HSCs in the FL. Different number of total FL cells (2 x10 4 or 5 x10 4 ) were transplanted with 2 x10 5 total BM cells as competitor cells into lethally irradiated recipient mice. The frequency of HSCs was calculated using L-Calc software (StemCell Technologies).
Intracellular staining for ER stress response genes
Freshly isolated or cultured c-kit + cells were stained with anti-CD48, -c-kit, -Sca-I, and -Lineage antibody mix. Then cells were fixed in Cytofix/Cytoperm TM Fixation and Permeabilization Solution (BD) for 30 min. The fixed cells were stained with following 90 % ethanol was dried up and dissolved in 1ml of 10 % acetonitrile (ACN) for adult liver or 0.1 ml of 10 % ACN for fetal liver.
Mass spectrometry analysis was carried out using TSQ Quantum Discovery Max mass spectrometer equipped with an ESI probe and Surveyor HPLC system (Thermo Fisher Scientific). A chromatographic separation column, InertSustain C18 column (150 mm x 2.1 mm I.D., 3 µm particle size; G&L Science) were employed at 35 ºC.
After injection of the sample solution, compounds were separated using an ACNaqueous ammonium acetate gradient. The mass spectrometry conditions, spray voltage, sheath gas pressure, collision energy etc. were set according to the previous reports (Muto et al., 2012; Naritaka et al., 2015) . Analyzed BAs are referenced in Table S2 .
Cell-free protein aggregation assay
BSA was mixed to 0.2 % (w/v) in PBS + 5 mM DTT. Different concentrations of BA were added to each well in a 96 well plate in triplicate: 0.5 mM, 1 mM, 5 mM and 10 mM. Plates were incubated at 75 °C and protein aggregation was measured at 492 nm (OD) every 15 min on Infinite® 200 microplate reader (Tecan).
Uptake of 3 H-TCA
Tritium labeled ( 3 H(G)) TCA (PerkinElmer) was incubated with HSPCs from adult BM and FL in Hanks balanced salt solution (HBSS) + 20 mM HEPES for 5, 10 and 15 min for time dependent uptake. FL-HSPCs were incubated with 3 H-TCA and 20 µM unlabeled TCA, TUDCA and TCDCA for 10 min in competitive setting. After incubation, cells were washed (x4) in cold HBSS +20 mM HEPES and lysed in RIPA
